Please login to the form below

Not currently logged in
Email:
Password:

iPierian

This page shows the latest iPierian news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

AbbVie and C2N take tau antibody into clinic

Last year, Bristol-Myers Squibb bought into the field via a $725m deal to acquire iPierian.

Latest news

  • BMS buys Alzheimer's player iPierian in $725m deal BMS buys Alzheimer's player iPierian in $725m deal

    BMS buys Alzheimer's player iPierian in $725m deal. Takes control of several promising candidates for neurodegenerative diseases. ... BMS has paid $175m upfront for iPierian, with the potential for additional development and regulatory milestone payments

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics